{
  "id": "clinical#management_a1c3ca64",
  "content": "304.60 (F16.20) Severe\n___.__ (___.__) Other Hallucinogen Use Disordera, b (246)\nSpecify the particular hallucinogen\nSpecify current severity:\n305.30 (F16.10) Mild\n304.50 (F16.20) Moderate\n304.50 (F16.20) Severe\n292.89 (___.__) Phencyclidine Intoxication (248)\n(F16.129) With use disorder, mild\n(F16.229) With use disorder, moderate or severe\n(F16.929) Without use disorder\n292.89 (___.__) Other Hallucinogen Intoxication (249)\n(F16.129) With use disorder, mild\n(F16.229) With use disorder, moderate or severe\n(F16.929) Without use disorder\n292.89 (F16.983)Hallucinogen Persisting Perception Disorder\n(250)\n___.__ (___.__) Other Phencyclidine-Induced Disorders (251)\n___.__ (___.__) Other Hallucinogen-Induced Disorders (251)\n292.9 (F16.99) Unspecified Phencyclidine-Related Disorder (252)\n292.9 (F16.99) Unspecified Hallucinogen-Related Disorder (252)\nInhalant-Related Disorders (252)\n___.__ (___.__) Inhalant Use Disordera, b (252)\nSpecify the particular inhalant\nSpecify current severity:\n305.90 (F18.10) Mild\n304.60 (F18.20) Moderate\n304.60 (F18.20) Severe\n292.89 (___.__) Inhalant Intoxication (254)\n(F18.129) With use disorder, mild\n(F18.229) With use disorder, moderate or severe\n(F18.929) Without use disorder\nDSM-5 Classification xxix\n___.__ (___.__) Other Inhalant-Induced Disorders (255)\n292.9 (F18.99) Unspecified Inhalant-Related Disorder (256)\nOpioid-Related Disorders (256)\n___.__ (___.__) Opioid Use Disordera (256)\nSpecify if: On maintenance therapy, In a controlled\nenvironment\nSpecify current severity:\n305.50 (F11.10) Mild\n304.00 (F11.20) Moderate\n304.00 (F11.20) Severe\n292.89 (___.__) Opioid Intoxicationc (258)\nWithout perceptual disturbances",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Management 304.60 (F16.20) Severe\n___.__ (___.__) Other Hallucinogen Use Disordera, b (246)\nSpecify the particular hallucinogen\nSpecify current severity:\n305.30 (F16.10) Mild\n304.50 (F16.20) Moderate\n304.50 (F16.20) Severe\n292.89 (___.__) Phencyclidine Intoxication (248)\n(F16.129) With use disorder, mild\n(F16.229) With use disorder, moderate or severe\n(F16.929) Without use disorder\n292.89 (___.__) Other Hallucinogen Intoxication (249)\n(F16.129) With use disorder, mild\n(F16.229) With use disorder, moderate or severe\n(F16.929) Without use disorder\n292.89 (F16.983)Hallucinogen Persisting Perception Disorder\n(250)\n___.__ (___.__) Other Phencyclidine-Induced Disorders (251)\n___.__ (___.__) Other Hallucinogen-Induced Disorders (251)\n292.9 (F16.99) Unspecified Phencyclidine-Related Disorder (252)\n292.9 (F16.99) Unspecified Hallucinogen-Related Disorder (252)\nInhalant-Related Disorders (252)\n___.__ (___.__) Inhalant Use Disordera, b (252)\nSpecify the particular inhalant\nSpecify current severity:\n305.90 (F18.10) Mild\n304.60 (F18.20) Moderate\n304.60 (F18.20) Severe\n292.89 (___.__) Inhalant Intoxication (254)\n(F18.129) With use disorder, mild\n(F18.229) With use disorder, moderate or severe\n(F18.929) Without use disorder\nDSM-5 Classification xxix\n___.__ (___.__) Other Inhalant-Induced Disorders (255)\n292.9 (F18.99) Unspecified Inhalant-Related Disorder (256)\nOpioid-Related Disorders (256)\n___.__ (___.__) Opioid Use Disordera (256)\nSpecify if: On maintenance therapy, In a controlled\nenvironment\nSpecify current severity:\n305.50 (F11.10) Mild\n304.00 (F11.20) Moderate\n304.00 (F11.20) Severe\n292.89 (___.__) Opioid Intoxicationc (258)\nWithout perceptual disturbances 304.60 (f16.20) severe\n___.__ (___.__) other hallucinogen use disordera, b (246)\nspecify the particular hallucinogen\nspecify current severity:\n305.30 (f16.10) mild\n304.50 (f16.20) moderate\n304.50 (f16.20) severe\n292.89 (..."
}